US Supplement Market Regulation: Depression Claim, Undisclosed Drug, COVID Tincture
Executive Summary
FDA warns 10 businesses they’re marketing unapproved and misbranded drugs by making claims for supplements to treat depression. Supplement also found with one of, if not the most common violations in the US supplement market: it contained an undisclosed ED drug.
You may also be interested in...
Next US FDA Commissioner Will Have Opening To Fill In Dietary Supplement Programs Office
Steven Tave on 15 March will move from ODSP director to lead ORA’s Office of Strategic Planning and Operational Policy. Agency’s next commissioner, who Capitol Hill lobbyists say could be named next week, will appoint a replacement.
Amazon Flexes E-Commerce Heft By Imposing Quality-Control Requirements For Supplements
Amazon requires firms selling supplements on its site in the US to demonstrate their products comply with FDA regulations for labeling and GMPs. Marketers that don’t submit documentation face removal of their products from the site.
Amazon’s VMS Policy Mirrors US FDA Rules But May Reflect Stronger Industry Compliance
Amazon’s requirements reach to guaranteeing ingredients are compliant with FDA regulations. While the agency, for the most part, isn’t preventing sales of supplements containing ingredients that have not been notified as NDIs with proof of reasonable expectation of safety, Amazon could ask marketers for the information.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: